231 related articles for article (PubMed ID: 23178438)
1. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States.
Maisonneuve P; Marshall BC; Knapp EA; Lowenfels AB
J Natl Cancer Inst; 2013 Jan; 105(2):122-9. PubMed ID: 23178438
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study.
Maisonneuve P; FitzSimmons SC; Neglia JP; Campbell PW; Lowenfels AB
J Natl Cancer Inst; 2003 Mar; 95(5):381-7. PubMed ID: 12618503
[TBL] [Abstract][Full Text] [Related]
3. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group.
Neglia JP; FitzSimmons SC; Maisonneuve P; Schöni MH; Schöni-Affolter F; Corey M; Lowenfels AB
N Engl J Med; 1995 Feb; 332(8):494-9. PubMed ID: 7830730
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence in the US radiologic technologists health study, 1983-1998.
Sigurdson AJ; Doody MM; Rao RS; Freedman DM; Alexander BH; Hauptmann M; Mohan AK; Yoshinaga S; Hill DA; Tarone R; Mabuchi K; Ron E; Linet MS
Cancer; 2003 Jun; 97(12):3080-9. PubMed ID: 12784345
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
10. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
12. Cholangitis and subsequent gastrointestinal cancer risk: a Danish population-based cohort study.
Søgaard KK; Erichsen R; Lund JL; Farkas DK; Sørensen HT
Gut; 2014 Feb; 63(2):356-61. PubMed ID: 23804559
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
14. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
Yamada A; Komaki Y; Komaki F; Micic D; Zullow S; Sakuraba A
Lancet Oncol; 2018 Jun; 19(6):758-767. PubMed ID: 29706374
[TBL] [Abstract][Full Text] [Related]
15. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
[TBL] [Abstract][Full Text] [Related]
16. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.
Jussila A; Virta LJ; Pukkala E; Färkkilä MA
Scand J Gastroenterol; 2013 Dec; 48(12):1405-13. PubMed ID: 24131389
[TBL] [Abstract][Full Text] [Related]
19. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
[TBL] [Abstract][Full Text] [Related]
20. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
Inskip PD
Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]